(NMDA) or potassium depolarization. Striatal 1996 bind to and inhibit the catalytic activity of calcineurin, thus increasing the phosphorylation of proteins that are calcineurin substrates (2, 3) . FK506 and CsA potently and selectively block neurotoxicity elicited by stimulation of the Nmethyl-D-aspartate (NMDA) subtype of glutamate receptors, which have been implicated in neuronal damage associated with strokes and neurodegenerative diseases (4) . This neuroprotective action appears related to enhanced phosphorylation of nitric oxide synthase (NOS) which inhibits NOS catalytic activity (4), as NOS inhibitors block NMDA neurotoxicity (5) .
Despite the high levels of brain immunophilins and their involvement in neurotoxicity, a physiologic role has remained elusive. The link between immunophilins and NOS suggested a possible participation in neurotransmitter release. Nitric oxide (NO) regulates neurotransmitter release, as NOS inhibitors block transmitter release in brain synaptosomes and PCi2 cells (6, 7) . Neurotransmitter release is also regulated by the phosphorylation state of synaptic vesicle proteins like synapsin I, whose enhanced phosphorylation is associated with increased transmitter release (8) (9) (10) 10 ,000 X g for 5 min. Pellets were resuspended in ice cold H20 + 50 mM NaF and 10 AM sodium pyrophosphate (to prevent dephosphorylation) for 30 min at 40C, followed by a 10,000 X g centrifugation to remove the lysed synaptosomes. The 10,000 X g supernatant was then centrifuged at 200,000 X g for 2 hr through a 150 mM sucrose cushion to recover 32P-labeled synaptic vesicles. 32P-labeled synaptic vesicle proteins were separated by SDS-polyacrylamide gel electrophoresis using the buffers of Laemmli (11), the gels dried down and autoradiograms were prepared.
For immunoblot analysis, proteins from replica SDS-gels were electrophoretically transferred to nitrocellulose and probed with affinity-purified anti-synapsin I Ig (graciously provided by Dr. Pietro DeCamilli, Yale University School of Medicine). The inhibition of neurotransmitter release by nitro-L-arginine confirmed our earlier findings indicating that NO regulates neurotransmitter release in PC12 cells and synaptosomes (7) . Inhibition of neurotransmitter release is elicited in a stereospecific fashion by isomers of N-methyl arginine and is reversed by L-arginine (7). Potassium depolarization induced release of neurotransmitters in PC 12 cells does not appear until 8 days following NGF treatment coincident with the first appearance of NOS immunoreactivity and enzyme activity (7, 14, 15) . FK506 enhances the phosphorylation of NOS which inhibits NOS catalytic activity (16) , accounting for the ability of FK506 to block NMDA-neurotoxicity in cortical cultures (4). We suggest that inhibition of neurotransmitter release in PC 12 cells by FK506 and CsA similarly derives from enhanced phosphorylation of NOS with inhibition of NO formation.
In PC 12 cells, where the release of transmitters is due to nitric oxide production, FK506 markedly inhibits potassium-induced ACh and dopamine release (Fig. 1) . However, in striatal synaptosomes, FK506 produces markedly different effects (Fig. 3) [3H]-norepinephrine release from hippocampal and cortical synaptosomes is also enhanced by FK506 (data not shown). How might one account for the finding that FK506 fails to inhibit potassium depolarizationevoked release of neurotransmitter from synaptosomes whereas it blocks NMDA-induced release? NOS neurons possess NMDA receptors (17) and normally respond to NMDA with enhanced formation of NO, which would diffuse to adjacent nerve terminals to elicit transmitter release. While NMDA acts only on a subset of the synaptosomal population, potassium depolarization would influence all synaptosomes including those that lack NMDA receptors and NOS, so that any influence of FK506 on NO-regulated neurotransmission would be obscured.
In our experiments, FK506 stimulates both spontaneous and potassium depolarization-induced transmitter release in synaptosomes. This effect might involve synaptic vesicle proteins such as synapsin I, synaptobrevin, and synaptotagmin. Phosphorylation of synapsin I correlates with enhanced neurotransmitter release (8, 9) . If phosphorylated proteins such as these are calcineurin substrates, then FK506 might enhance their phosphorylation, thereby facilitating transmitter release. In the crude synaptic vesicle fraction isolated from striatal synaptosomes, FK506 augments the phosphorylation state of several proteins including those with apparent SDSpolyacrylamide gel molecular weights of 50 kD, 58-60 kD, a doublet of about 70-75 kD, 120 kD, and 350 kD (Fig. 4) (Fig. 4) (19, 20) . In nerve terminals, calcineurin may serve as a Ca2+-sensitive switch for depolarization-evoked synaptic vesicle recycling (19, 20 the presence of 100 nM FK506. Synaptosomes were lysed, and the crude synaptic vesicle fraction was recovered following centrifugation as described in Materials and Methods. The 32P-labelled synaptic vesicle proteins from untreated and 100 nM FK506-treated synaptosomes were resolved by gel electrophoresis, the gels were dried, and an autoradiogram was prepared. Immunoblot analysis of these samples probed with anti-synapsin I Ig demonstrated equivalent amounts of synapsin in each fraction. Molecular weight markers in kilodaltons are indicated. (b) 32p_ labelled synapsin I was immunoprecipitated from phosphorylated striatal synaptosomes treated with FK506 or buffer containing 0.01% ethanol (the vehicle for FK506) as described in Materials and Methods. Duplicate samples of anti-synapsin I immunoprecipitates from control and FK506-treated synaptosomes were resolved by gel electrophoresis, gels dried down, and an autoradiogram was prepared. Synapsin I is indicated by the arrow at 73-75 kDa. Molecular weight markers are indicated in kilodaltons.
learning and information storage, are regulated by calcium-dependent phosphorylation/dephosphorylation (21) . Calcineurin has been implicated in the generation of LTD in hippocampal slices, as FK506 inhibits this process (22 
